News | June 04, 2007

GE Sets PET Motion Free at SNM

June 5, 2007 - GE Healthcare introduced at SNM a new version of the company’s Discovery Dimension designed to help clinicians advance towards the goal of motion free PET/CT imaging, addressing the PET and CT imaging mismatches related to respiratory and cardiac motion. These include motion correction techniques that effectively improve clinical results and minimize blur caused by motion.
Discovery Dimension provides high definition PET image processing, patient motion management and clinical productivity features that together address motion, which is one of the most significant factors in lesion characterization that degrade PET/CT image quality.
“Our use of PET and CT 4-D respiratory motion imaging provides improved lesion detectability, quantitative accuracy and valuable information for radiation treatment planning,” said Professor Ferruccio Fazio, Director of Hospital San Raffaele (HSR) PET and Radiotherapy Center Milan, Italy. “All are significant in the comparative assessment of lesions in follow up studies before and after therapy.”


Related Content

News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 18, 2024
Home
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Home June 14, 2024
Home
News | PET Imaging

October 5, 2023 — Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
News | PET Imaging

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

Home December 01, 2022
Home
News | PET Imaging

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
News | PET Imaging

August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

Home August 25, 2022
Home
News | PET Imaging

June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Home June 15, 2022
Home
Technology | PET Imaging

December 5, 2018 — Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...

Home December 05, 2018
Home
News | PET Imaging

July 17, 2018 — A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new ...

Home July 17, 2018
Home
News | PET Imaging

July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...

Home July 07, 2017
Home
Subscribe Now